Home » Topics » BioWorld Science

BioWorld Science
RSS

HM-81422 as a novel treatment option for patients with HCC with altered FGF19/FGFR4 pathway

May 8, 2018

FDA approves IND for female hair loss trial of Histogen's HSC-660

May 7, 2018

New mutation in SLC20A2 gene found in Fahr's disease

May 7, 2018

ORR data from KEYNOTE-407 trial of Keytruda in first-line NSCLC support sBLA submission

May 7, 2018

Charles River Laboratories extends collaboration with Michael J. Fox Foundation

May 7, 2018

Novel ELOVL4 gene mutation tied to spinocerebellar ataxia with retinitis pigmentosa

May 7, 2018

monARC Bionetworks begins strategic integration with Roivant drug development platform

May 7, 2018

Lilly initiates phase III study of mirikizumab in moderate to severe plaque psoriasis

May 7, 2018

FDA grants priority review to Tecentriq sBLA for first-line treatment of metastatic NSCLC

May 7, 2018

Evolve doses first pediatric patient in phase III trial of PlasmaCap IG

May 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...